摘要
目的:观察中药内异康胶囊治疗子宫内膜异位症的疗效。方法:进行中药内异康胶囊组(试验组)及西药丹那唑组(对照组)各50例临床疗效观察。其诊断标准与疗效标准采用我国卫生部颁发中药新药治疗盆腔子宫内膜异位症的临床研究指导原则的标准,试验组口服内异康胶囊,每日二次,每次6粒(0.38g/粒),疗程6个月,对照组口服丹那唑,每日三次,每次200mg,连服6个月。结果:在治疗后不育患者受孕率(P<0.05),复发率(P<0.01),试验组均优于对照组;但对附件包块及盆腔结节的疗效两组相近。结论:提示中药内异康胶囊治疗子宫内膜异位症疗效可靠,无毒副作用。
Objective: To observe the clinical treatment of the Chinese Tracditional Medicin “Neiyikang” capsule to Endometrlosis. Methods: There was compared of the Clinical Treatment of 50 patients in every group of the Neiyikang group (Test) with Danazol group (control). Result: The Test group than control group excelleted ofter treatment of patients conception rate ( P〈 0.05) and recurrence rate ( P 〈 0.01 ), was significant differented, and also test group with control group was similar of the treatment for appendix mass and pelvic nede. Conclusion: The effect was definite of the patients of the treatment with Chinese Traditional Medicin “Neiyikang” capsule to Endometriosis, and not side effect.
出处
《华西医学》
CAS
2005年第3期494-495,共2页
West China Medical Journal
基金
四川省重点科技攻关项目(03SG022-019)